Doctors are taking the blame for the opioid epidemic. It’s time to push back.

The opioid epidemic has a favorite shortcut: find a doctor, point a finger, and call it accountability. It is a tidy story, and tidy stories tend to do well in headlines, legislative hearings, and social media posts built for outrage. But tidy stories can also be terribly wrong. If we want to understand the opioid crisis as it exists todaynot as it existed in the era of pill mills, blockbuster pain marketing, and OxyContin sales pitches dressed up like medical progresswe need to admit something uncomfortable. Doctors were part of the problem, but they are not the whole problem, and pretending otherwise has made the response weaker, colder, and less honest.

That is the case for pushing back. Not to deny the damage of reckless prescribing. Not to erase the role of clinicians who prescribed too freely or ignored obvious warning signs. And certainly not to hand the health care system a halo it did not earn. The point is simpler: the epidemic evolved, but much of the blame stayed frozen in the first chapter. Meanwhile, patients with legitimate pain got caught in the crossfire, physicians became afraid to treat suffering, and illicit fentanyl moved in like an arsonist while the country kept lecturing the smoke alarm.

The easy villain story is appealingand incomplete

There is a reason the “bad doctor caused the opioid crisis” narrative stuck. In the 1990s and 2000s, opioid prescribing rose dramatically. Pharmaceutical marketing minimized addiction risk, some professional norms shifted too far toward aggressive pain treatment, and certain prescribers wrote dangerous quantities with alarming casualness. The phrase “pill mill” did not appear out of thin air. Some doctors absolutely caused harm, and some did so at scale.

But that still does not justify turning all physicians into the main character in a one-note morality play. Public health disasters are almost never powered by one profession alone. The opioid epidemic was shaped by drug manufacturers that promoted misleading messages, distributors that flooded communities, pharmacies that dispensed suspicious volumes, regulators that missed warning signs, insurers that underpaid for comprehensive pain care, and policymakers who often preferred symbolic crackdowns to thoughtful systems reform.

Blaming doctors alone is emotionally satisfying in the way flat-pack furniture looks easy before you open the box. Then the screws spill everywhere, the instructions turn philosophical, and you realize the structure holding the whole thing up is much more complicated than advertised.

Yes, prescribing played a major role. No, that is not the whole modern epidemic.

The first phase was heavily tied to prescription opioids

The historical record matters. Rising opioid prescribing helped fuel the first wave of overdose deaths. Some patients developed opioid use disorder after exposure to prescription pain medication. Others diverted pills to friends, relatives, or the illegal market. Physicians who ignored risk, failed to monitor patients, or chased profit deserve scrutiny. So do the companies that trained them badly, marketed aggressively, and normalized long-term opioid use without good evidence for safety or effectiveness in many chronic pain settings.

That part should not be softened. It should be remembered accurately.

The crisis then changeddramatically

What gets lost in the doctor-blame script is that the overdose crisis did not stand still. Over time, heroin surged. Then illicitly manufactured fentanyl and fentanyl analogs transformed the risk environment entirely. Counterfeit pills and contaminated drug supplies made overdose more likely, faster, and harder to predict. The contemporary epidemic is not simply a rerun of overprescribing. It is a far deadlier, more chaotic drug-supply crisis.

That distinction matters because policy built for 2008 will fail in 2026. A physician can write fewer opioid prescriptions and still do very little to stop a fentanyl-laced counterfeit pill from killing a teenager, a person with untreated addiction, or someone using cocaine they did not know was contaminated. When the market shifts from medical prescribing to illicit synthetic opioids, the response has to shift too. Too often, it did not.

What happened when fear replaced nuance

Once doctors became the easiest target, medicine changed in ways that were not always wise. Some physicians stopped prescribing opioids almost entirely, even when patients had complex, painful, function-limiting conditions. Others inherited patients on long-term opioid therapy and saw them as legal hazards before they saw them as human beings. Pain clinics closed. Primary care practices refused certain patients. Abrupt tapers and forced discontinuations became common enough that federal agencies eventually had to warn against them.

That is one of the cruelest ironies in this story. In the effort to correct dangerous prescribing, parts of the system ended up punishing patients who were stable, monitored, and using medication responsibly. Some people with severe chronic pain found themselves rapidly tapered, cut off, or abandoned. When that happens, pain does not politely leave the building. It gets worse. Function drops. Trust collapses. In some cases, desperate people seek relief elsewhere, including the illicit market that policymakers claim to fear.

Fear-based medicine is still bad medicine, even when it is wearing a public-health badge.

Doctors are not wrong to say: enough with the scapegoating

Physicians should push back against lazy blame for several reasons.

1. Because clinical reality is not the same as a courtroom narrative

In court or in politics, broad stories are useful. In clinic rooms, they are dangerous. Pain is heterogeneous. Addiction risk is heterogeneous. Cancer pain, postoperative pain, sickle cell pain, palliative care, severe neuropathy, traumatic injury, and long-term chronic pain do not fit into one slogan. Doctors are trained to individualize care for a reason. When they are forced into rigid thresholds, blanket restrictions, or one-size-fits-all suspicion, patients lose.

2. Because medicine has already changed dramatically

Prescribing has fallen substantially over the last decade. That did not happen by accident. Clinicians changed practice, states tightened rules, prescription monitoring expanded, and health systems increased scrutiny. Yet overdose deaths continued to be driven overwhelmingly by illicit fentanyl and other substances. That should have ended the simplistic idea that punishing prescribers alone would solve the epidemic. Instead, many doctors kept absorbing the political heat long after the center of gravity moved elsewhere.

3. Because undertreated pain is also a public-health problem

There is a fashionable tendency to talk as though the only morally serious risk is addiction. But severe uncontrolled pain can destroy quality of life, employment, mobility, sleep, mood, and family stability. It can deepen depression and increase isolation. A humane system should be able to say two things at once: opioids carry real risks, and some patients still need them. That is not ideological confusion. That is adulthood.

4. Because the epidemic was industrial as well as clinical

Drug manufacturers and distributors did not merely observe the opioid crisis from a tasteful distance. They shaped it. So did pharmacies and regulatory systems that failed to stop suspicious patterns early enough. If the national conversation keeps circling back to doctors as the single symbol of fault, it lets other institutions appear as background scenery when many were active participants.

What a smarter response looks like

Pushing back on doctor scapegoating is not a call to return to the wild-west days of indiscriminate opioid prescribing. It is a call for a response grounded in present-day facts.

Treat pain like a real medical condition, not a public-relations inconvenience

Patients need access to multimodal pain care: physical therapy, behavioral health support, interventional options when appropriate, nonopioid medications, rehabilitation, and, for selected patients, opioid therapy with careful monitoring. The phrase “nonopioid first” can be sensible. The phrase “opioids never” is not medicine; it is branding.

Treat addiction with the urgency we claim to feel

If policymakers truly want fewer overdose deaths, they must expand evidence-based treatment for opioid use disorder, including buprenorphine and methadone, reduce barriers to care, support emergency department initiation, improve follow-up, and normalize long-term treatment. Addiction is not improved by making it harder to get treatment than to get fentanyl. That is not a strategy. That is an administrative prank played on vulnerable people.

Use harm reduction like we mean it

Naloxone distribution, fentanyl test strips where legal, syringe services, overdose education, and outreach to high-risk communities save lives. These are not fringe ideas anymore. They are essential tools in a drug supply that is faster, deadlier, and less predictable than the prescription-dominant environment of the past.

Hold the right institutions accountable

Accountability should not stop with individual prescribers. It should extend to the corporate and regulatory actors that helped normalize unsafe opioid expansion, failed to flag suspicious shipping and dispensing patterns, and profited while communities absorbed the damage. A crisis this large does not emerge from one exam room at a time. It is built by systems.

Protect individualized medicine

Doctors need room to use judgment without being pushed into reckless prescribing or defensive under-prescribing. Good policy should discourage dangerous practices while leaving room for patient-centered care. The moment clinicians become more afraid of regulators than concerned with the person in front of them, care distorts. And when care distorts, patients notice first.

The argument physicians should make now

Doctors should not argue that they bear no responsibility. That case would be false and unpersuasive. The stronger argument is this: physicians were one part of a changing epidemic, many doctors corrected course, and it is both clinically irresponsible and morally lazy to treat them as the central cause of today’s overdose emergency.

They should say that rigid opioid panic has hurt patients. They should say that abruptly cutting stable patients off can be dangerous. They should say that illicit fentanyl, counterfeit pills, stimulant contamination, fragmented mental health care, untreated addiction, and weak access to evidence-based treatment are now central drivers of mortality. They should say that pain care deserves nuance, not slogans. And they should say all of it without apology.

Because the longer the country argues with the wrong version of the epidemic, the longer people keep dying in the real one.

What this looks like in real life: the experience behind the argument

Talk to enough clinicians, patients, and families, and a pattern appears. A primary care doctor inherits a middle-aged patient with a spinal injury, multiple surgeries, and years of stable opioid treatment. The chart is thick, the imaging is ugly, and the patient is functioning just well enough to keep a job. The physician knows the public script: be cautious, taper if possible, avoid risk. But the patient is not a headline. He is a person who has finally found a fragile equilibrium. The doctor spends the visit doing a calculation that has become common in modern medicine: what is more dangerous here, the drug itself or the fear surrounding it?

Then there is the emergency physician who sees the other end of the epidemic. The overdose patient in front of her did not get fentanyl from a legitimate prescription. He bought what he thought was a pill from a friend of a friend. Or he used cocaine that was contaminated. Or he relapsed after being out of treatment for weeks because follow-up care was scarce, insurance hurdles were endless, and transportation was unreliable. In that room, the old narrative about overprescribing feels incomplete. The crisis is now mixed up with counterfeit drugs, unstable housing, trauma, untreated psychiatric illness, and a treatment system that too often requires people to be highly organized while their lives are in pieces.

There is also the pain patient who did everything “right.” She signed agreements, passed drug screens, kept appointments, used one pharmacy, and took her medication exactly as prescribed. Then a policy change hits, or a clinic changes ownership, or a physician retires. Suddenly the tone shifts. She is no longer treated as a patient with a difficult condition; she is treated as a compliance problem. Her dose is cut quickly. Her pain spikes. Sleep disappears. Work becomes shaky. Family members notice she is less present, more frightened, less mobile. None of this makes for a dramatic public speech, but it is part of the lived cost of converting clinical care into reputation management.

Many doctors feel trapped too. Some worry that prescribing opioids, even appropriately, could invite scrutiny or professional risk. Others worry that refusing to prescribe will leave patients suffering or push them toward unsafe alternatives. This tension is emotionally corrosive. Physicians are asked to relieve pain, prevent addiction, avoid legal exposure, interpret shifting guidance, and absorb public anger for a crisis shaped by forces much bigger than any single clinic. Burnout thrives in that kind of moral fog.

And families live with the consequences of every bad simplification. Some families have lost loved ones after years of exposure to prescription opioids that should have been handled more carefully. Others have lost loved ones to fentanyl bought on the street after medical care fell apart. Some are caring for relatives with chronic pain who feel discarded by the health system. Others are fighting every week to keep a son or daughter in treatment for opioid use disorder. Different stories, same lesson: blame alone is a poor substitute for strategy.

That is why pushing back matters. Not to protect bad medicine. To protect honest medicine. To make room for doctors to treat pain thoughtfully, addiction aggressively, and patients humanely. The opioid epidemic is too serious for caricatures. It calls for accountability, yesbut also accuracy. And accuracy begins with saying out loud that the burden of blame has fallen too neatly on physicians, long after the crisis outgrew that explanation.

Conclusion

The opioid epidemic did not begin in one place, and it certainly does not live in one place now. Doctors helped create part of the crisis, some grievously so, but the modern emergency is larger than prescribing. It is a fentanyl crisis, a treatment-access crisis, a mental-health crisis, a regulatory failure, and in many communities, a social-fracture crisis. Pushing back against doctor scapegoating is not denial. It is a demand for a more accurate map. And when lives are on the line, the country needs a mapnot another finger-pointing contest dressed up as policy.